CIK 0001665988
- Accelerated filer
- Emerging growth company
Bioventus Inc.
Sign in to watch- Ticker
- BVS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 810980861
- Phone
- +1 919-474-6700
- Business address
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
- 4 Open-market sale SVP & Chief Science Officer sold 32,997 shares at $11.17 ($368,425)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 23,416 shares (option exercise)
- 4 Exercise or conversion Director acquired 2,700 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale SVP & Chief Science Officer sold 433 shares at $11.99 ($5,192)
- 4 Exercise or conversion SVP & Chief Science Officer acquired 1,470 shares (option exercise)
- 4 Exercise or conversion Director acquired 9,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 9,000 shares (option exercise)
- 4 Open-market sale SVP & General Counsel sold 1,294 shares at $11.99 ($15,513)
- 4 Open-market sale SVP & CFO sold 1,294 shares at $11.99 ($15,518)
- 4 Open-market sale Chief Commercial Officer sold 534 shares at $11.99 ($6,401)
- 4 Exercise or conversion Director acquired 9,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 9,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 13,500 shares (option exercise)
- 4 Exercise or conversion Director acquired 9,000 shares (option exercise)
- 4 Shares withheld for taxes SVP & CHIEF SCIENCE OFFICER gave up 73,915 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF COMMERCIAL OFFICER gave up 24,205 shares (to pay taxes)
- 4 Shares withheld for taxes SVP & General Counsel gave up 6,599 shares (to pay taxes)
- 4 Shares withheld for taxes SVP & CFO gave up 19,674 shares (to pay taxes)
Page 10 of 13 · 251 filings